Genetic Technologies Reports Q1 FY22 Results
Genetype MultiTest submitted for regulatory approval as commercialization plans gather momentum increase in cash receipts over prior quarter ...
Source: globenewswire.com
Stay updated with breaking news from Predictive Panel Risk Test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Genetype MultiTest submitted for regulatory approval as commercialization plans gather momentum increase in cash receipts over prior quarter ...